Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Facing challenges in saving for a house? Explore effective strategies to overcome obstacles and boost your savings.
9,628 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Across software-as-a-service stocks, Wix has been a standout case of a dramatic pullback. This piece breaks down why ...
The Pentagon unveils a sweeping overhaul of officer education, banning eight elite institutions and authorizing nine ...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Kickstarter’s stands 4-day workweek, a bold move for a remote-first company. The CEO says it balances life with high ...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
A new privacy law takes effect March 5, ending broad trigger-lead marketing for loans. Lenders must pivot to consent-...
Target stock surged after the latest earnings release, sending investors back to the question: is this the start of a...
Prediction markets are pricing a surprisingly small cost for a big Bitcoin bet. This article explains what traders pa...
Webull’s March-quarter results reveal a bold pivot: the CEO says B2B revenue could rival or surpass retail in the com...
February delivered a sharp move for Iren Limited as the market wrestled with a bold pivot from neocloud mining to AI ...
A sudden move lower in AeroVironment stock has traders and long-term holders asking what happened. This guide breaks ...